Allakos Inc

General ticker "ALLK" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $94.8M

Allakos Inc does not follow the US Stock Market performance with the rate: -20.7%.

Estimated limits based on current volatility of 5.6%: low 1.21$, high 1.35$

Factors to consider:

  • Current price 21.8% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.62$, 4.47$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.52$, 4.12$]

Financial Metrics affecting the ALLK estimates:

  • Negative: Non-GAAP EPS, $ of -2.13 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -33.20 <= 2.35
  • Negative: negative Net income
  • Positive: Investing cash flow per share, $ of 1.07 > -0.12
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term ALLK quotes

Long-term ALLK plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $271.48MM $322.43MM $196.06MM
Operating Income $-271.48MM $-322.43MM $-196.06MM
Non-Operating Income $1.61MM $2.48MM $10.36MM
Interest Expense $0.00MM $3.67MM $0.00MM
R&D Expense $196.33MM $265.08MM $150.91MM
Income(Loss) $-269.86MM $-319.95MM $-185.70MM
Profit(Loss) $-269.86MM $-319.95MM $-185.70MM
Stockholders Equity $445.48MM $310.43MM $168.82MM
Assets $534.82MM $386.42MM $243.61MM
Operating Cash Flow $-207.85MM $-279.97MM $-116.48MM
Capital expenditure $33.22MM $8.33MM $0.59MM
Investing Cash Flow $143.24MM $71.68MM $93.17MM
Financing Cash Flow $10.26MM $141.88MM $2.53MM
Earnings Per Share* $-4.96 $-5.02 $-2.14

* EPS are Split Adjusted, recent splits may be reflected with a delay.